- Scholarly Journal
The Interplay Between lncRNAs–microRNAs Network Dysregulation and Cellular Hallmarks of Thyroid Cancer
PDF
CiteCite
Copy URL
https://www.proquest.com/scholarly-journals/interplay-between-lncrnas-micrornas-network/docview/3265839561/se-2?accountid=208611
PrintAll OptionsReferences (164)
- 1.
The tumor therapeutic potential of long non-coding RNA delivery and targeting
Han, S; Chen, X; Huang, L. Acta Pharm. Sin. B.- Times cited 2 on ProQuest
- 2.
Long non-coding RNAs: from disease code to drug role
Chen, Y; Li, Z; Chen, X; Zhang, S. Acta Pharm Sin B Vol. 11, Iss. 2, .- Times cited 2 on ProQuest
- 3.
LncRNA GLTC targets LDHA for succinylation and enzymatic activity to promote progression and radioiodine resistance in papillary thyroid cancer
L Shi; R Duan; Z Sun; Q Jia; W Wu; F Wang; J Liu; H Zhang; X Xue. Cell Death Differ Vol. 30, .- Times cited 15 on ProQuest
- 4.
MALAT1: A druggable long non-coding RNA for targeted anti-cancer approaches
N Amodio; L Raimondi; G Juli; MA Stamato; D Caracciolo; P Tagliaferri; P Tassone. J Hematol Oncol Vol. 11, .- Times cited 13 on ProQuest
- 5.
A systematic review of non-coding RNA therapeutics in early clinical trials: A new perspective against cancer
K Grillone; G Caridà; F Luciano; A Cordua; MT Di Martino; P Tagliaferri; P Tassone. J Transl Med Vol. 22, .- Times cited 8 on ProQuest
- 6.
Long non-coding RNA ASMTL-AS1 inhibits tumor growth and glycolysis by regulating the miR-93-3p/miR-660/FOXO1 axis in papillary thyroid carcinoma
Z Feng; R Chen; N Huang; C Luo. Life Sci Vol. 244, Iss. 117298, .- Times cited 2 on ProQuest
- 8.
Identification of an interactome network between lncRNAs and miRNAs in thyroid cancer reveals SPTY2D1-AS1 as a new tumor suppressor
Ramírez-Moya, J; Wert-Lamas, L; Acuña-Ruíz, A; Fletcher, A; Wert-Carvajal, C; McCabe, C; Santisteban, P; Riesco-Eizaguirre, G. Sci. Rep Vol. 12, Iss. 1, .- Times cited 2 on ProQuest
- 9.
Hejazi, Maryam; Jafari, Tahmineh; Yari, AmirHossein; Heshmat, Ramin; Larijani, Bagher; et al. Medical Oncology; Middlesex Vol. 42, Iss. 10, (Oct 2025): 448.A novel long non-coding RNA, PICSAR, promotes thyroid cancer progression through the hsa-miR-320A/hsa-miR-485/RAPGEFL1 axis - 10.
Zhang, Dechun; Pei, Shaoxuan; Feng, Zixuan; Xia, Guangfeng. Journal of Translational Medicine; London Vol. 23, Iss. 1, (Dec 2025): 689.Functions and mechanisms of lncRNAs in immune escape and their application in immunotherapy for colorectal cancer - 11.
Mu, Deyang; Han, Bing; Huang, Hao; Zheng, Yuchen; Zhang, Jungang; et al. Journal of Translational Medicine; London Vol. 23, Iss. 1, (Dec 2025): 614.Unraveling the advances of non-coding RNAs on the tumor microenvironment: innovative strategies for cancer therapies - 12.
Forma Alicja; Kłodnicka Karolina; Pająk Weronika; Flieger Jolanta; Teresińska, Barbara; et al. International Journal of Molecular Sciences; Basel Vol. 26, Iss. 11, (2025): 5173.Thyroid Cancer: Epidemiology, Classification, Risk Factors, Diagnostic and Prognostic Markers, and Current Treatment Strategies - 13.
Chen, Junxin; Chen, Yue; Huang, Rong; Zhang, Pengyuan; Huo, Zijun; et al. Journal of Endocrinological Investigation; Heidelberg Vol. 48, Iss. 5, (May 2025): 1121-1136.Long noncoding RNA FAM111A-DT promotes aggressiveness of papillary thyroid cancer via activating NF-κB signaling - 14.
Scientific Reports (Nature Publisher Group); London Vol. 15, Iss. 1, (2025): 12190.Integrative analysis of ceRNA networks and immune cell infiltration in thyroid cancer for enhanced diagnostic and prognostic insights - 15.
Scientific Reports (Nature Publisher Group); London Vol. 15, Iss. 1, (2025): 7971.Improvement of carboplatin chemosensitivity in lung cancer cells by siRNA-mediated downregulation of DLGAP1-AS2 expression - 16.
Gugnoni, Mila; Kashyap, Manoj Kumar; Wary, Kishore K; Ciarrocchi, Alessia. Molecular Cancer; London Vol. 24, Iss. 1, (Dec 2025): 38.lncRNAs: the unexpected link between protein synthesis and cancer adaptation